Article Details

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Retrieved on: 2021-03-16 11:03:33

Tags for this article:

Click the tags to see associated articles and topics

Inflammatix nets $102M to advance its immune system tests for infectious diseases. View article details on hiswai:

Excerpt

... Capital Partners alongside backing from the company's previous investors Northpond Ventures, Khosla Ventures, Think.Health and OSF Healthcare ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo